Si Ying Ma

Part of China Biologic Products Holdings, Inc., Shandong Taibang Biological Products Co. Ltd. is a Chinese company that manufactures and wholesales biological products. The company is based in Tai'an, China. The company was founded in 2002. Guang Li Pang has been the CEO of the company since 2002.

Beijing Huamei Fude Medical Technology Co., Ltd. engages in technology development, and technical advisory services. Its business activities include business management consulting, investment advisory, and wholesale of medical equipment. The company was founded on July 9, 2015 and is headquartered in Beijing, China.

Taibang Biotech (Shandong) Co., Ltd. engages in research and development in biotechnological products. Its products include biopharmaceuticals, biochemical pharmaceuticals, blood products, vaccines, and diagnostic reagents. The company was founded on December 21, 2009 and is headquartered in Tai'an, China.

Beijing Jingdu Children's Hospital operates as a private children's hospital. Its departments include stomatology, emergency, surgical, internal medicine, pediatric, traditional Chinese medicine, otolaryngology, ophthalmology, dermatology, infectious diseases, anesthesia, neurological rehabilitation, clinical nutrition, medical imaging, ultrasound, pharmaceutical preparation, clinical electrocardiographic room, electroencephalogram (EEG) room, and peripherally-inserted central catheters (PICC) outpatient service. The company was founded on January 28, 2015 and is headquartered in Beijing, China.

Beijing Meizhong Airui Cancer Hospital Co., Ltd. is a third-level tumor specialist consultation hospital founded in 2017. The company is based in Beijing, China. The hospital offers a variety of tumor expert consultations and has eight major clinic centers, including lung cancer, breast, gynecological tumor, gastrointestinal tumor, hepatobiliary tumor, urinary tumor, tumor consultation, and tumor sieve recovery. Additionally, the hospital has multiple medical technical departments such as tumor radiation images, tumor pathology, tumor radiotherapy, tumor ultrasound, and tumor early screen intervention inspection.